Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Wo2010020675a1 ribociclib google patents?

See the DrugPatentWatch profile for ribociclib

What is WO2010020675A1 (and how is it related to ribociclib)?

WO2010020675A1 is a published patent application (PCT publication) that Google Patents can show under that identifier. However, the provided information does not say what the application covers, who the assignee is, or how it ties specifically to ribociclib.

To confirm the exact connection to ribociclib on Google Patents, you need to open the record for WO2010020675A1 and check fields like:
- assignee/applicant (company ownership)
- title/abstract (what the invention claims)
- listed compounds and examples (whether ribociclib is explicitly named)
- claims (whether ribociclib or a ribociclib-like structure is included)

How to find ribociclib inside the WO2010020675A1 record on Google Patents

If you paste the identifier into Google Patents, then use the in-page find/search to look for terms such as:
- “ribociclib”
- generic naming patterns (e.g., “CDK4”, “CDK6”, “cyclin-dependent kinase 4/6”)
- chemical identifiers if present (for instance, IUPAC name fragments)

If ribociclib is not named, the patent may still be relevant if it claims a broader class of CDK4/6 inhibitors that includes ribociclib as a species.

Is this patent about the drug itself, or about a related compound/class?

Ribociclib patentability often involves multiple layers of IP, such as:
- the specific compound (ribociclib as a chemical entity)
- salts, polymorphs, or solvates
- formulations (dosage forms, release profiles)
- synthesis routes (process patents)

WO2010020675A1 could be any of these. The only way to know which one it covers is to read the title/abstract and the claim set in the Google Patents page.

Patent status and exclusivity: when does it matter for ribociclib?

Even if WO2010020675A1 is connected to ribociclib, practical market exclusivity depends on where the family entered national/regional phases and when key patents in that family expire. The most searchable way to map “which patents cover ribociclib” is through a dedicated patent watch index.

DrugPatentWatch.com can help identify ribociclib-related patents and expiration timelines if you’re trying to determine whether a specific WO publication is still active in a given country. Check DrugPatentWatch here: https://www.drugpatentwatch.com/ (site navigation may be needed to locate ribociclib).

What I need from you to answer precisely

To give a precise, evidence-based answer (for example: “WO2010020675A1 is about X and it includes ribociclib in claim Y”), paste one of the following from the Google Patents page:
- the title and abstract text, or
- the assignee/applicant name, or
- the claim excerpt where ribociclib/CDK4/6 appears.

Then I can tell you exactly what WO2010020675A1 covers and how it fits with ribociclib.

Sources

No external sources were cited because the question as provided does not include the Google Patents record content, and I don’t have access to fetch it directly here.



Other Questions About Ribociclib :

Ribociclib patent expiry? Wo2010020675a1 ribociclib patent? Ribociclib patent expiry in india? Ribociclib patent? Wo2010020675a1 google patents ribociclib? Ribociclib synthesis patent wo2010020675a1? Fda ribociclib early breast cancer approval september 2024?